ESMO Events 2025
Meetings opens in new tab/window | ESMO opens in new tab/window
Welcome to our ESMO Virtual Congress site where we showcase the very best from ESMO's flagship portfolio.
ESMO Sarcoma and Rare Cancers Congress 2025 opens in new tab/window
Whether you are a seasoned oncologist, a dedicated researcher, a healthcare professional, a pharmaceutical industry leader, or a patient advocate, this event offers something for everyone committed to advancing the care and improving outcomes of patients with sarcomas and rare cancers. Below a collection of papers recently published in ESMO’s premier journals carefully selected to reflect the themes of the meeting.
Annals of Oncology
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse opens in new tab/window J.-Y. Blay; C. Schiffler; O. Bouché; M. Brahmi; F. Duffaud; M. Toulmonde; B. Landi; W. Lahlou; D. Pannier; E. Bompas; F. Bertucci; L. Chaigneau; O. Collard; M. Pracht; C. Henon; I. Ray-Coquard; K. Armoun; S. Salas; M. Spalato-Ceruso; A. Adenis; B. Verret; N. Penel; C. Moreau-Bachelard; A. Italiano; A. Dufresne; S. Metzger; S. Chabaud; D. Perol; A. Le Cesne
Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study opens in new tab/window P. Sargos, MD; M.P. Sunyach, MD; A. Ducassou, MD; C. Llacer, MD; D. Dinart, PhD; A. Michot, MD; T. Valentin, MD; N. Firmin, MD; J.Y. Blay, MD PhD; P. Gillon, MD; C. Bellera, PhD; A. Italiano, MD PhD
ESMO Open
Efficacy, safety, and pharmacokinetics of eribulin as monotherapy or in combination with irinotecan for patients with pediatric rhabdomyosarcoma, non-rhabdomyosarcoma soft tissue sarcoma, or Ewing sarcoma opens in new tab/window M. Casanova; C.M. Albert; F. Bautista; S.C. Borinstein; S. Bradfield; A. Bukowinski; Q. Campbell-Hewson; D.S. Hawkins; A. Kim; G.M. Milano; L.V. Marshall; N. Pinto; C.A. Pratilas; A. Rubio-San-Simón; R. Windsor; O. Majid; R. Scott; Y. Jia; C. Paoletti; U. Kontny
Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications opens in new tab/window C. Park; R. Kim; J.M. Bae; T. Lee; S. Song; Y. Kwak; K.B. Lee; J. Youk; B. Keam; T.M. Kim; D.-W. Kim; J.-I. Kim; J. Choi; M. Kim
Immuno-Oncology and Technology
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy opens in new tab/window C. Carcopino; E. Erdogan; M. Henrich; S. Kobold
Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma opens in new tab/window T.J. Monberg; T. Kudling; B. Albieri; S. Pakola; E. Ellebaek; M. Donia; R.L. Eefsen; C. von Buchwald; C. Kistler; J.M. Santos; J. Clubb; L. Haybout; M.C.W. Westergaard; D.C.A. Quixabeira; E. Jirovec; R. Havunen; S. Sorsa; V. Cervera-Carrascon; A. Hemminki; I.M. Svane
ESMO Gastrointestinal Oncology
Gastrin-releasing peptide receptor expression in gastrointestinal stromal tumours opens in new tab/window M. Berndsen; F. Puls; A. Thornell; Y. Arvidsson; A. Muth; S. Lindskog; E. Elias
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignancies opens in new tab/window L. Weiss; D. Zhang; W.G. Kunz; S. Boeck; G. Curigliano; V. Subbiah; F. Lordick; T. Brummer; C.B. Westphalen; L. Boscolo Bielo
ESMO Real World Data and Digital Oncology
Real-world treatment patterns and challenges of patients with biliary tract cancer: retrospective chart review survey in Europe (GARNET-2) opens in new tab/window J. Bridgewater; J. Sah; A. Szende; M. Paskow; P. Messina; B. Baur; J.M. Banales
Head and Neck Sarcoma Assessor (HaNSA) for treatment decisions using real-world data opens in new tab/window M.Y.S. See; J.J.N. Goh; C.E. Low; C.E. Yau; W.S. Ong; R.X. Wong; N.F. Mohamed Noor; M.H.B.H. Mohamed; J.T. Suha; A.N.H. Sairi; W.L. Goh; X.Y. Woo; V.S. Yang
ESMO affiliated journals
Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study opens in new tab/window Stijn J.C. van der Burg; Sophie J.M. Reijers; Anke Kuijpers; Lotte Heimans; Astrid N. Scholten; Rick L.M. Haas; Hester van Boven; Willemijn M. Kolff; Marie-Jeanne T.F.D. Vrancken Peeters; Martijn Kerst; Beatrijs A. Seinstra; Neeltje Steeghs; Winette T.A. van der Graaf; Yvonne M. Schrage; Winan J. van Houdt
Personalized treatment strategies for breast adenoid cystic carcinoma: A machine learning approach opens in new tab/window Sakhr Alshwayyat; Mahmoud Bashar Abu Al Hawa; Mustafa Alshwayyat; Tala Abdulsalam Alshwayyat; Siya sawan; Ghaith Heilat; Hanan M. Hammouri; Sara Mheid; Batool Al Shweiat; Hamdah Hanifa
Functioning neuroendocrine tumors (NET): Minimum requirements for a NET specialist opens in new tab/window F. Spada; R.E. Rossi; R. Modica; F. Gelsomino; M. Rinzivillo; M. Rubino; E. Pisa; A.La Salvia; N. Fazio
Primary mediastinal large B-cell Lymphoma: Biological features, clinical characteristics and current treatment strategies opens in new tab/window Livia Donzelli; Alice Di Rocco; Luigi Petrucci; Maurizio Martelli
Primary pulmonary adenoid cystic carcinoma: A study of clinicopathological features and molecular alterations in twenty-one cases opens in new tab/window Zhiyuan Yao; Tong Qiu; Changlei Li; Weimao Kong; Guangqi Li; Peng Song; Guohua Wang; Wenjie Jiao
Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53 opens in new tab/window Mingying Wu; Na Zhou; Mei Guan; Yingyi Wang; Yuzhou Wang
Clinical Impact of Next-Generation Sequencing of T-Cell Lymphomas: A Single Institution Experience opens in new tab/window Omar Elghawy; Julia Wang; Olivia J. Leung; Nishwant Swami; Veronica Carvajal; Guang Yang; Daniel J. Landsburg; Jakub Svoboda; Sunita D. Nasta; Elise A. Chong; Stephen J. Schuster; Colin J. Thomas; Jordan S. Carter; Adam Bagg; Stefan K. Barta
A Real-World Evaluation of Frontline Treatment for Acute Myeloid Leukemia With Azacitidine Plus Venetoclax opens in new tab/window Joseph Brandwein; David Page; Elena Liew; Mark Hnatiuk; Lauren Bolster; Marlene Hamilton; Daniel Sawler; Peng Wang
ESMO's Journal Portfolio
While diverse in nature and in content, these journals offer ESMO members and the oncology community a highly visible platform to publish important scientific studies, and a highly credible source for educational updates. Elsevier is the proud publisher of Annals of Oncology, Immuno-Oncology and Technology (IOTECH), ESMO Open, ESMO Gastrointestinal Oncology, ESMO Real World Data and Digital Oncology, ESMO Rare Cancers, and ESMO Affiliated Journals The Breast, Lung Cancer, Cancer Treatment Reviews and Clinical Lymphoma Myeloma and Leukemia.
